Literature DB >> 17133246

Anakinra for the treatment of neonatal-onset multisystem inflammatory disease.

Hal M Hoffman1, Gary S Firestein.   

Abstract

Entities:  

Year:  2006        PMID： 17133246     DOI： 10.1038/ncprheum0350

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN： 1745-8382


× No keyword cloud information.
  5 in total

Review 1.  The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders.

Authors:  H E Barksby; S R Lea; P M Preshaw; J J Taylor
Journal:  Clin Exp Immunol       Date:  2007-06-21       Impact factor: 4.330

2.  Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease.

Authors:  Frank L van de Veerdonk; Sanne P Smeekens; Leo A B Joosten; Bart Jan Kullberg; Charles A Dinarello; Jos W M van der Meer; Mihai G Netea
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

Review 3.  Drugs for paediatric hyperinflammatory syndromes.

Authors:  Kam Lun Hon; Alexander Kc Leung; Wing Hang Leung; Karen Ka Yan Leung; Kai Ning Cheong; Pamela Pw Lee
Journal:  Drugs Context       Date:  2022-05-27

Review 4.  Pain management in gout.

Authors:  Brian S Kirby; Joan C McTigue; N Lawrence Edwards
Journal:  Curr Pain Headache Rep       Date:  2008-12

5.  The role of the NLRP3 inflammasome in gout.

Authors:  Sarah R Kingsbury; Philip G Conaghan; Michael F McDermott
Journal:  J Inflamm Res       Date:  2011-03-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.